# A Randomized Trial of Human Growth Hormone (hGH) vs Placebo in Intensively Treated Haemato-Oncology Patients.

> **NCT00300664** · PHASE2,PHASE3 · COMPLETED · sponsor: **Royal Marsden NHS Foundation Trust** · enrollment: 150 (—)

## Conditions studied

- Multiple Myeloma
- Acute Lymphoblastic Leukemia
- Acute Myeloid Leukemia
- Myelodysplastic Syndrome

## Interventions

- **DRUG:** Human Growth hormone

## Key facts

- **NCT ID:** NCT00300664
- **Lead sponsor:** Royal Marsden NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-07
- **Primary completion:** —
- **Final completion:** 2005-04
- **Target enrollment:** 150 (—)
- **Last updated:** 2006-10-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00300664

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00300664, "A Randomized Trial of Human Growth Hormone (hGH) vs Placebo in Intensively Treated Haemato-Oncology Patients.". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT00300664. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*